Tiger Brokers

Mainz Biomed NV Enters Equity Distribution Agreement for Up to $10 Million in Ordinary Share Sales, Including $2.3 Million via Shelf Registration Statement

Reuters
Oct 04
Mainz Biomed NV Enters <a href="https://laohu8.com/S/EQD">Equity Distribution</a> Agreement for Up to $10 Million in Ordinary Share Sales, Including $2.3 Million via Shelf Registration Statement

**Mainz Biomed NV Enters $10 Million Equity Distribution Agreement** Mainz Biomed NV announced it has entered into an Equity Distribution Agreement with Maxim Group LLC, allowing the company to sell up to $10,000,000 of its ordinary shares (€0.40 nominal value each) through Maxim as sales agent. The agreement enables Mainz Biomed to sell shares from time to time, with up to $2,300,000 of shares to be sold under an effective shelf registration statement. Maxim Group LLC will receive a 3% commission on gross sales. The document does not specify the total number of shares or the exact price per share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mainz Biomed NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-096195), on October 03, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10